Toll-like receptors (TLRs) play crucial roles in the recognition of invading pathogens and the immune system. However, the effect of TLRs in asthma is still not fully known. This study was performed to better understand the role of TLR signatures in asthma. Blood samples from case–control studies (study 1: 348 asthmas and 39 normal controls and validation study 2: 411 asthmas and 87 normal controls) were enrolled. The single-sample gene set enrichment analysis method was performed to quantify the abundance of 21 TLR signatures. Gene ontology analysis and pathway function analysis were conducted for functional analysis, and a protein–protein interaction network was constructed. The area under the curve (AUC) value was used to assess the diagnostic capacity. In this study, TLR2/TLR3/TLR4 pathway, MyD88-dependent/independent TLR pathway, positive regulation of TLR4 pathway, and TLR binding signatures were significantly higher in asthma. Functional analysis showed that biological processes and pathways were still involved in TLR cascades and TLR signaling pathway. Eleven hub TLR-related genes were identified, and further validation demonstrated that the combination of TLR-related genes was a good diagnostic biomarker for asthma (AUC = 0.8). Our study provided more insight into the underlying immune mechanism of how TLR signatures affected asthma. The use of the easy-to-apply TLR-related genes might represent a promising blood-based biomarker for early detection of asthma.
Get full access to this article
View all access options for this article.
References
1.
AlexisN., EldridgeM., ReedW., BrombergP., and PedenD.B. (2001). CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J Allergy Clin Immunol, 107, 31–35.
2.
AroraS., AhmadS., IrshadR., GoyalY., RafatS., SiddiquiN., et al. (2019). TLRs in pulmonary diseases. Life Sci, 233, 116671.
3.
Ayala-CuellarA.P., ChoJ., and ChoiK.C. (2019). Toll-like receptors: a pathway alluding to cancer control. J Cell Physiol, 234, 21707–21715.
4.
BergerA.C., KorkutA., KanchiR.S., HegdeA.M., LenoirW., LiuW., et al. (2018). A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell, 33, 690.e699–705.e699.
5.
BhallaA., MukherjeeM., and NairP. (2018). Airway eosinophilopoietic and autoimmune mechanisms of eosinophilia in severe asthma. Immunol Allergy Clin North Am, 38, 639–654.
6.
BindeaG., MlecnikB., TosoliniM., KirilovskyA., WaldnerM., ObenaufA. C., et al. (2013). Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity, 39, 782–795.
7.
BiswasS.K. (2015). Metabolic reprogramming of immune cells in cancer progression. Immunity, 43, 435–449.
8.
BoonpiyathadT., SozenerZ.C., SatitsuksanoaP., and AkdisC.A. (2019). Immunologic mechanisms in asthma. Semin Immunol, 46, 101333.
CatesE.A., ConnorE.E., MosserD.M., and BannermanD.D. (2009). Functional characterization of bovine TIRAP and MyD88 in mediating bacterial lipopolysaccharide-induced endothelial NF-kappaB activation and apoptosis. Comp Immunol Microbiol Infect Dis, 32, 477–490.
11.
ChenK., XiangY., YaoX., LiuY., GongW., YoshimuraT., et al. (2011). The active contribution of Toll-like receptors to allergic airway inflammation. Int Immunopharmacol, 11, 1391–1398.
12.
ChunE., LeeS.H., LeeS.Y., ShimE.J., ChoS.H., MinK.U., et al. (2010). Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol, 30, 459–464.
13.
DayaM., RafaelsN., BrunettiT.M., ChavanS., LevinA.M., ShettyA., et al. (2019). Association study in African-admixed populations across the Americas recapitulates asthma risk loci in non-African populations. Nat Commun, 10, 880.
14.
DouT., FuM., WangY., ZhaoY., WangZ., BianZ., et al. (2013). Signatures of positive selection in LY96 gene in vertebrates. J Biosci, 38, 899–904.
15.
FinotelloF., and TrajanoskiZ. (2018). Quantifying tumor-infiltrating immune cells from transcriptomics data. Cancer Immunol Immunother, 67, 1031–1040.
16.
FitzgeraldK.A., and KaganJ.C. (2020). Toll-like receptors and the control of immunity. Cell, 180, 1044–1066.
17.
GraysonM.H., FeldmanS., PrinceB.T., PatelP.J., MatsuiE.C., and ApterA.J. (2018). Advances in asthma in 2017: mechanisms, biologics, and genetics. J Allergy Clin Immunol, 142, 1423–1436.
HazzardW.R. (1989). Geriatric education programs in North Carolina. Response to the demographic imperative. N C Med J, 50, 92–93.
20.
HoldbrookD.A., HuberR.G., MarzinekJ.K., StubbuschA., SchmidtchenA., and BondP.J. (2019). Multiscale modeling of innate immune receptors: endotoxin recognition and regulation by host defense peptides. Pharmacol Res, 147, 104372.
21.
HolgateS.T. (2012). Innate and adaptive immune responses in asthma. Nat Med, 18, 673–683.
22.
JavaidN., YasmeenF., and ChoiS. (2019). Toll-like receptors and relevant emerging therapeutics with reference to delivery methods. Pharmaceutics, 11, 441.
23.
JonesC.M., and AthanasiouT. (2005). Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg, 79, 16–20.
24.
KfouryA., VirardF., RennoT., and CosteI. (2014). Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic intervention. Curr Opin Oncol, 26, 86–91.
25.
KhalafK., PaolettiG., PuggioniF., RaccaF., De LucaF., GiorgisV., et al. (2019). Asthma from immune pathogenesis to precision medicine. Semin Immunol, 46, 101294.
26.
KhanI., Ul-HaqZ., ShaheenA., ZamanM., AhmadN., AbbasiR., et al. (2018). Association of arg16gly and gln27glu, b2-adrenergic receptor gene polymorphism with asthma. A systematic review and meta-analysis of case control studies. J Pak Med Assoc, 68, 90–97.
27.
LeekJ.T., JohnsonW.E., ParkerH.S., JaffeA.E., and StoreyJ.D. (2012). The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics, 28, 882–883.
28.
LoftusP.A., and WiseS.K. (2016). Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg, 24, 245–249.
29.
MillsK.H. (2011). TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol, 11, 807–822.
30.
NabihE.S., KamelH.F., and KamelT.B. (2016). Association between CD14 polymorphism (-1145G/A) and childhood bronchial asthma. Biochem Genet, 54, 50–60.
31.
ObuchowskiN.A., and BullenJ.A. (2018). Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol, 63, 07TR01.
32.
PatelP.S., and KearneyJ.F. (2017). CD36 and platelet-activating factor receptor promote house dust mite allergy development. J Immunol, 199, 1184–1195.
33.
PfaarO., AgacheI., de BlayF., BoniniS., ChakerA.M., DurhamS.R., et al. (2019). Perspectives in allergen immunotherapy: 2019 and beyond. Allergy, 74,(Suppl. 108), 3–25.
34.
PhillipsJ.E., RenteriaL., BurnsL., HarrisP., PengR., BauerC.M., et al. (2016). Btk inhibitor RN983 delivered by dry powder nose-only aerosol inhalation inhibits bronchoconstriction and pulmonary inflammation in the ovalbumin allergic mouse model of asthma. J Aerosol Med Pulm Drug Deliv, 29, 233–241.
35.
ShangL., WangL., ShiX., WangN., ZhaoL., WangJ., et al. (2020). HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-kappaB signal pathway in asthma. Life Sci, 241, 117120.
36.
SharmaS., PoonA., HimesB.E., Lasky-SuJ., SordilloJ.E., BelangerK., et al. (2012). Association of variants in innate immune genes with asthma and eczema. Pediatr Allergy Immunol, 23, 315–323.
37.
SilversteinR.L., and FebbraioM. (2009). CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal, 2, re3.
38.
SingerJ.W., FleischmanA., Al-FayoumiS., MascarenhasJ.O., YuQ., and AgarwalA. (2018). Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy. Oncotarget, 9, 33416–33439.
39.
TesseR., PandeyR.C., and KabeschM. (2011). Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy, 66, 307–316.
40.
TizaouiK., KaabachiW., HamzaouiK., and HamzaouiA. (2015). Association of single nucleotide polymorphisms in toll-like receptor genes with asthma risk: a systematic review and meta-analysis. Allergy Asthma Immunol Res, 7, 130–140.
VijayK. (2018). Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol, 59, 391–412.
43.
WangS.B., and HuangT. (2019). The early detection of asthma based on blood gene expression. Mol Biol Rep, 46, 217–223.
44.
ZakeriA., & RussoM. (2018). Dual role of toll-like receptors in human and experimental asthma models. Front Immunol, 9, 1027.
45.
ZanoniI., and GranucciF. (2013). Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol, 3, 32.
46.
ZhangQ., FuX.L., QianF.H., CaoQ., MaoZ.D., BaiJ.L., et al. (2016). Polymorphisms in Toll-like receptor 3 are associated with asthma-related phenotypes in the Chinese Han patients. Int J Immunogenet, 43, 383–390.
47.
ZhaoJ., ShangH., CaoX., HuangY., FangX., ZhangS., et al. (2017). Association of polymorphisms in TLR2 and TLR4 with asthma risk: an update meta-analysis. Medicine (Baltimore), 96, e7909.
48.
ZhouY., ZhouB., PacheL., ChangM., KhodabakhshiA.H., TanaseichukO., et al. (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun, 10, 1523.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
